bioRxivCancer BiologyPreprint
Intracellular interaction of FNDC1/FN1/AR/cMYC in prostate cancer cells
Abstract
MicroRNAs play an important role in modulating normal cellular functions through protein-protein interaction in addition to regulating gene expression via mRNA degradation or translational repression. PVT1 is a non-protein coding gene that encodes six annotated microRNAs (miRNAs), including miR-1207-3p, a demonstrated modulator in PCa. MiR-1207-3p is significantly underexpressed in PCa cells when compared to normal prostatic cells and directly targets fibronectin type III domain containing 1 (FNDC1), which was found to be overexpressed in PCa cells along with concomitant overexpression of fibronectin (FN1)/androgen receptor (AR)/c-MYC. To better understand the role of FNDC1/FN1/AR/c-MYC in PCa progression we examined the interaction between FNDC1/FN1/AR/c-MYC. Coimmunoprecipitation study showed direct physical interaction between FNDC1/FN1/AR/c-MYC in PCa cells and FN1/AR/cMYC in normal prostatic cell. Knockdown of FN1, AR and cMYC not only confirmed FN1/FNDC1/AR/cMYC interaction but also gave rise to the possibility of a complex. We also examined the spatial localization of the FNDC1/FN1/AR/c-MYC pathway by performing immunofluorescence staining in PCa cells. Single staining analysis revealed that FNDC1, AR and c-MYC localize to the nucleus and cytoplasm while FN1 localizes only to the cytoplasm in PCa cells but not in the non-tumorigenic prostate cells. However, our findings show that miR-1207-3p has no direct effect on the FNDC1/FN1/AR/cMYC interaction. Understanding this molecular interaction can reveal additional insights into the role of FNDC1/FN1/AR/cMYC interaction in PCa progression.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cell Type-Specific Effects of miR-21 Loss Attenuate Tumor Progression in MYC-Driven Prostate Cancer
Kenji Zennami, Mindy Kim Graham, … Shawn E. Lupold·bioRxiv·May 14, 2025
- MicroRNA-194 promotes lineage plasticity in advanced prostate cancer
R. C. Fernandes, J. Toubia, … L. Selth·bioRxiv·Sep 12, 2019
- Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer
B. Kumar, A. Z. Rosenberg, … S. E. Lupold·bioRxiv·Jan 20, 2018
- MEIS1 down-regulation by MYC mediates prostate cancer development through elevated HOXB13 expression and AR activity
N. C. Whitlock, S. Y. Trostel, … A. G. Sowalsky·bioRxiv·Nov 20, 2019
- miR-100-5p downregulates mTOR to suppress the proliferation, migration and invasion of prostate cancer cells
s. li, Y. Ye, J.-j. Wang·bioRxiv·Jul 30, 2020
- MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets
Xintao Qiu, Nadia Boufaied, … David P. Labbé·Nature CommunicationsPeer-reviewed·May 13, 2022